APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologic Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biologic Drugs Industry Growth and Trends Forecast to 2032

26 December 2025104 pages

Choose your research edition.

Industry ResearchBiologic Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biologic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Biologic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biologic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biologic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biologic Drugs include Abbott Laboratories, Amgen, Amgen, Pfizer, Eli Lilly, Roche, Merck & Co., Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biologic Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biologic Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biologic Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biologic Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Biologic Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biologic Drugs Market by Company

Abbott Laboratories

Amgen

Amgen

Pfizer

Eli Lilly

Roche

Merck & Co.

Novartis

Johnson & Johnson

Sanofi

Biologic Drugs Segment by Type

Humira

Avastin

Enbrel

Herceptin

Lantus

Remicade

Rituxan

Others

Biologic Drugs Segment by Application

Auto-Immune Diseases

Inflammation

Blood Diseases

Cardiovascular Diseases

Diabetes

Others

Biologic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biologic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Biologic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Humira Table 2. Major Company of Avastin Table 3. Major Company of Enbrel Table 4. Major Company of Herceptin Table 5. Major Company of Lantus Table 6. Major Company of Remicade Table 7. Major Company of Rituxan Table 8. Major Company of Others Table 9. Global Biologic Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 10. Global Biologic Drugs Sales by Type (2021-2026) & (K Units) Table 11. Global Biologic Drugs Sales Market Share in Volume by Type (2021-2026) Table 12. Global Biologic Drugs Sales by Type (2021-2026) & (US$ Million) Table 13. Global Biologic Drugs Sales Market Share in Value by Type (2021-2026) Table 14. Global Biologic Drugs Price by Type (2021-2026) & (US$/Unit) Table 15. Global Biologic Drugs Sales by Type (2027-2032) & (K Units) Table 16. Global Biologic Drugs Sales Market Share in Volume by Type (2027-2032) Table 17. Global Biologic Drugs Sales by Type (2027-2032) & (US$ Million) Table 18. Global Biologic Drugs Sales Market Share in Value by Type (2027-2032) Table 19. Global Biologic Drugs Price by Type (2027-2032) & (US$/Unit) Table 20. North America Biologic Drugs Sales by Type (2021-2026) & (K Units) Table 21. North America Biologic Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Europe Biologic Drugs Sales by Type (2021-2026) & (K Units) Table 23. Europe Biologic Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Asia-Pacific Biologic Drugs Sales by Type (2021-2026) & (K Units) Table 25. Asia-Pacific Biologic Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Latin America Biologic Drugs Sales by Type (2021-2026) & (K Units) Table 27. Latin America Biologic Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Middle East and Africa Biologic Drugs Sales by Type (2021-2026) & (K Units) Table 29. Middle East and Africa Biologic Drugs Sales by Type (2021-2026) & (US$ Million) Table 30. Biologic Drugs Industry Trends Table 31. Biologic Drugs Industry Drivers Table 32. Biologic Drugs Industry Opportunities and Challenges Table 33. Biologic Drugs Industry Restraints Table 34. Global Biologic Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 35. Global Biologic Drugs Revenue Market Share by Company (2021-2026) Table 36. Global Biologic Drugs Sales by Company (2021-2026) & (K Units) Table 37. Global Biologic Drugs Sales Share by Company (2021-2026) Table 38. Global Biologic Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 39. Global Biologic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 40. Global Biologic Drugs Major Company Production Sites and Headquarters Table 41. Global Biologic Drugs Company, Product Type & Application Table 42. Global Biologic Drugs Company Establishment Date Table 43. Global Company Market Concentration Ratio (CR5 and HHI) Table 44. Global Biologic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 45. Global Biologic Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 46. Global Biologic Drugs Sales by Region (2021-2026) & (K Units) Table 47. Global Biologic Drugs Sales Market Share in Volume by Region (2021-2026) Table 48. Global Biologic Drugs Sales by Region (2021-2026) & (US$ Million) Table 49. Global Biologic Drugs Sales Market Share in Value by Region (2021-2026) Table 50. Global Biologic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Global Biologic Drugs Sales by Region (2027-2032) & (K Units) Table 52. Global Biologic Drugs Sales Market Share in Volume by Region (2027-2032) Table 53. Global Biologic Drugs Sales by Region (2027-2032) & (US$ Million) Table 54. Global Biologic Drugs Sales Market Share in Value by Region (2027-2032) Table 55. Global Biologic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 56. Global Biologic Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 57. Global Biologic Drugs Sales by Application (2021-2026) & (K Units) Table 58. Global Biologic Drugs Sales Market Share in Volume by Application (2021-2026) Table 59. Global Biologic Drugs Sales by Application (2021-2026) & (US$ Million) Table 60. Global Biologic Drugs Sales Market Share in Value by Application (2021-2026) Table 61. Global Biologic Drugs Price by Application (2021-2026) & (US$/Unit) Table 62. Global Biologic Drugs Sales by Application (2027-2032) & (K Units) Table 63. Global Biologic Drugs Sales Market Share in Volume by Application (2027-2032) Table 64. Global Biologic Drugs Sales by Application (2027-2032) & (US$ Million) Table 65. Global Biologic Drugs Sales Market Share in Value by Application (2027-2032) Table 66. Global Biologic Drugs Price by Application (2027-2032) & (US$/Unit) Table 67. North America Biologic Drugs Sales by Application (2021-2026) & (K Units) Table 68. North America Biologic Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Europe Biologic Drugs Sales by Application (2021-2026) & (K Units) Table 70. Europe Biologic Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Asia-Pacific Biologic Drugs Sales by Application (2021-2026) & (K Units) Table 72. Asia-Pacific Biologic Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Latin America Biologic Drugs Sales by Application (2021-2026) & (K Units) Table 74. Latin America Biologic Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Middle East and Africa Biologic Drugs Sales by Application (2021-2026) & (K Units) Table 76. Middle East and Africa Biologic Drugs Sales by Application (2021-2026) & (US$ Million) Table 77. Abbott Laboratories Company Information Table 78. Abbott Laboratories Business Overview Table 79. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Abbott Laboratories Biologic Drugs Product Portfolio Table 81. Abbott Laboratories Recent Development Table 82. Amgen Company Information Table 83. Amgen Business Overview Table 84. Amgen Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Amgen Biologic Drugs Product Portfolio Table 86. Amgen Recent Development Table 87. Amgen Company Information Table 88. Amgen Business Overview Table 89. Amgen Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Amgen Biologic Drugs Product Portfolio Table 91. Amgen Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pfizer Biologic Drugs Product Portfolio Table 96. Pfizer Recent Development Table 97. Eli Lilly Company Information Table 98. Eli Lilly Business Overview Table 99. Eli Lilly Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Eli Lilly Biologic Drugs Product Portfolio Table 101. Eli Lilly Recent Development Table 102. Roche Company Information Table 103. Roche Business Overview Table 104. Roche Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Roche Biologic Drugs Product Portfolio Table 106. Roche Recent Development Table 107. Merck & Co. Company Information Table 108. Merck & Co. Business Overview Table 109. Merck & Co. Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Merck & Co. Biologic Drugs Product Portfolio Table 111. Merck & Co. Recent Development Table 112. Novartis Company Information Table 113. Novartis Business Overview Table 114. Novartis Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Novartis Biologic Drugs Product Portfolio Table 116. Novartis Recent Development Table 117. Johnson & Johnson Company Information Table 118. Johnson & Johnson Business Overview Table 119. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Johnson & Johnson Biologic Drugs Product Portfolio Table 121. Johnson & Johnson Recent Development Table 122. Sanofi Company Information Table 123. Sanofi Business Overview Table 124. Sanofi Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sanofi Biologic Drugs Product Portfolio Table 126. Sanofi Recent Development Table 127. North America Biologic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Biologic Drugs Sales by Country (2021-2026) & (K Units) Table 129. North America Biologic Drugs Sales Market Share by Country (2021-2026) Table 130. North America Biologic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Biologic Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. North America Biologic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Biologic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Biologic Drugs Market Share by Country (2021-2026) Table 135. North America Biologic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Biologic Drugs Market Share Forecast by Country (2027-2032) Table 137. Europe Biologic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Biologic Drugs Sales by Country (2021-2026) & (K Units) Table 139. Europe Biologic Drugs Sales Market Share by Country (2021-2026) Table 140. Europe Biologic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Biologic Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Biologic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Biologic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Biologic Drugs Market Share by Country (2021-2026) Table 145. Europe Biologic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Biologic Drugs Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Biologic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Biologic Drugs Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Biologic Drugs Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Biologic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Biologic Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Biologic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Biologic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Biologic Drugs Market Share by Country (2021-2026) Table 155. Asia-Pacific Biologic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Biologic Drugs Market Share Forecast by Country (2027-2032) Table 157. Latin America Biologic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Biologic Drugs Sales by Country (2021-2026) & (K Units) Table 159. Latin America Biologic Drugs Sales Market Share by Country (2021-2026) Table 160. Latin America Biologic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Biologic Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Biologic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Biologic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Biologic Drugs Market Share by Country (2021-2026) Table 165. Latin America Biologic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Biologic Drugs Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Biologic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Biologic Drugs Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Biologic Drugs Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Biologic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Biologic Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Biologic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Biologic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Biologic Drugs Market Share by Country (2021-2026) Table 175. Middle East and Africa Biologic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Biologic Drugs Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Biologic Drugs Distributors List Table 180. Biologic Drugs Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Biologic Drugs Image Figure 2. Global Biologic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Biologic Drugs Sales (2021-2032) & (K Units) Figure 5. Humira Image Figure 6. Global Humira Sales YoY Growth (2021-2032) & (K Units) Figure 7. Avastin Image Figure 8. Global Avastin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Enbrel Image Figure 10. Global Enbrel Sales YoY Growth (2021-2032) & (K Units) Figure 11. Herceptin Image Figure 12. Global Herceptin Sales YoY Growth (2021-2032) & (K Units) Figure 13. Lantus Image Figure 14. Global Lantus Sales YoY Growth (2021-2032) & (K Units) Figure 15. Remicade Image Figure 16. Global Remicade Sales YoY Growth (2021-2032) & (K Units) Figure 17. Rituxan Image Figure 18. Global Rituxan Sales YoY Growth (2021-2032) & (K Units) Figure 19. Others Image Figure 20. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 21. Global Biologic Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 22. Global Biologic Drugs Market Share by Type 2025 VS 2032 Figure 23. North America Biologic Drugs Sales Market Share in Volume by Type in 2025 Figure 24. North America Biologic Drugs Sales Market Share in Value by Type in 2025 Figure 25. Europe Biologic Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Europe Biologic Drugs Sales Market Share in Value by Type in 2025 Figure 27. Asia-Pacific Biologic Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Asia-Pacific Biologic Drugs Sales Market Share in Value by Type in 2025 Figure 29. Latin America Biologic Drugs Sales Market Share in Volume by Type in 2025 Figure 30. Latin America Biologic Drugs Sales Market Share in Value by Type in 2025 Figure 31. Middle East and Africa Biologic Drugs Sales Market Share in Volume by Type in 2025 Figure 32. Middle East and Africa Biologic Drugs Sales Market Share in Value by Type in 2025 Figure 33. Global Top 5 and 10 Biologic Drugs Players Market Share by Revenue in 2025 Figure 34. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Auto-Immune Diseases Image Figure 36. Global Auto-Immune Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 37. Inflammation Image Figure 38. Global Inflammation Sales YoY Growth (2021-2032) & (K Units) Figure 39. Blood Diseases Image Figure 40. Global Blood Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 41. Cardiovascular Diseases Image Figure 42. Global Cardiovascular Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 43. Diabetes Image Figure 44. Global Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 45. Others Image Figure 46. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 47. Global Biologic Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 48. Global Biologic Drugs Market Share by Application 2025 VS 2032 Figure 49. North America Biologic Drugs Sales Market Share in Volume by Application in 2025 Figure 50. North America Biologic Drugs Sales Market Share in Value by Application in 2025 Figure 51. Europe Biologic Drugs Sales Market Share in Volume by Application in 2025 Figure 52. Europe Biologic Drugs Sales Market Share in Value by Application in 2025 Figure 53. Asia-Pacific Biologic Drugs Sales Market Share in Volume by Application in 2025 Figure 54. Asia-Pacific Biologic Drugs Sales Market Share in Value by Application in 2025 Figure 55. Latin America Biologic Drugs Sales Market Share in Volume by Application in 2025 Figure 56. Latin America Biologic Drugs Sales Market Share in Value by Application in 2025 Figure 57. Middle East and Africa Biologic Drugs Sales Market Share in Volume by Application in 2025 Figure 58. Middle East and Africa Biologic Drugs Sales Market Share in Value by Application in 2025 Figure 59. North America Biologic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. North America Biologic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. North America Biologic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. North America Biologic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Biologic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Europe Biologic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Biologic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Europe Biologic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Biologic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Asia-Pacific Biologic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Asia-Pacific Biologic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Asia-Pacific Biologic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Latin America Biologic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 72. Latin America Biologic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Latin America Biologic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Latin America Biologic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Middle East and Africa Biologic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 76. Middle East and Africa Biologic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 77. Middle East and Africa Biologic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 78. Middle East and Africa Biologic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 79. Biologic Drugs Value Chain Figure 80. Key Raw Materials Price Figure 81. Manufacturing Cost Structure Figure 82. Biologic Drugs Production Mode & Process Figure 83. Direct Comparison with Distribution Share Figure 84. Distributors Profiles Figure 85. Years Considered Figure 86. Research Process Figure 87. Key Executives Interviewed

Scope & coverage.

Types
  • Humira
  • Avastin
  • Enbrel
  • Herceptin
  • Lantus
  • Remicade
  • Rituxan
  • Others
Applications
  • Auto-Immune Diseases
  • Inflammation
  • Blood Diseases
  • Cardiovascular Diseases
  • Diabetes
  • Others
Companies covered
  • Abbott Laboratories
  • Amgen
  • Amgen
  • Pfizer
  • Eli Lilly
  • Roche
  • Merck & Co.
  • Novartis
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biologic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Biologic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Biologic Drugs Market by Type
  6. 1.3.1 Humira
  7. 1.3.2 Avastin
  8. 1.3.3 Enbrel
  9. 1.3.4 Herceptin
  10. 1.3.5 Lantus
  11. 1.3.6 Remicade
  12. 1.3.7 Rituxan
  13. 1.3.8 Others
  14. 1.4 Global Biologic Drugs Market Size by Type
  15. 1.4.1 Global Biologic Drugs Market Size Overview by Type (2021-2032)
  16. 1.4.2 Global Biologic Drugs Historic Market Size Review by Type (2021-2026)
  17. 1.4.3 Global Biologic Drugs Forecasted Market Size by Type (2027-2032)
  18. 1.5 Key Regions Market Size by Type
  19. 1.5.1 North America Biologic Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.2 Europe Biologic Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.3 Asia-Pacific Biologic Drugs Sales Breakdown by Type (2021-2026)
  22. 1.5.4 South America Biologic Drugs Sales Breakdown by Type (2021-2026)
  23. 1.5.5 Middle East and Africa Biologic Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Biologic Drugs Industry Trends
  2. 2.2 Biologic Drugs Industry Drivers
  3. 2.3 Biologic Drugs Industry Opportunities and Challenges
  4. 2.4 Biologic Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Biologic Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Biologic Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Biologic Drugs Price (2021-2026)
  4. 3.4 Global Biologic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biologic Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Biologic Drugs Company, Product Type & Application
  7. 3.7 Global Biologic Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biologic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biologic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biologic Drugs Tier 1, Tier 2, and Tier 3
4 Biologic Drugs Regional Status and Outlook
  1. 4.1 Global Biologic Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Biologic Drugs Historic Market Size by Region
  3. 4.2.1 Global Biologic Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Biologic Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Biologic Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Biologic Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Biologic Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Biologic Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Biologic Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Biologic Drugs by Application
  1. 5.1 Biologic Drugs Market by Application
  2. 5.1.1 Auto-Immune Diseases
  3. 5.1.2 Inflammation
  4. 5.1.3 Blood Diseases
  5. 5.1.4 Cardiovascular Diseases
  6. 5.1.5 Diabetes
  7. 5.1.6 Others
  8. 5.2 Global Biologic Drugs Market Size by Application
  9. 5.2.1 Global Biologic Drugs Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Biologic Drugs Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Biologic Drugs Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Biologic Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Biologic Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Biologic Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Biologic Drugs Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Biologic Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories Biologic Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Laboratories Biologic Drugs Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 Amgen
  8. 6.2.1 Amgen Company Information
  9. 6.2.2 Amgen Business Overview
  10. 6.2.3 Amgen Biologic Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Biologic Drugs Product Portfolio
  12. 6.2.5 Amgen Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Biologic Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Biologic Drugs Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Biologic Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Biologic Drugs Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Biologic Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Biologic Drugs Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Biologic Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roche Biologic Drugs Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Merck & Co.
  38. 6.7.1 Merck & Co. Company Information
  39. 6.7.2 Merck & Co. Business Overview
  40. 6.7.3 Merck & Co. Biologic Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck & Co. Biologic Drugs Product Portfolio
  42. 6.7.5 Merck & Co. Recent Developments
  43. 6.8 Novartis
  44. 6.8.1 Novartis Company Information
  45. 6.8.2 Novartis Business Overview
  46. 6.8.3 Novartis Biologic Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novartis Biologic Drugs Product Portfolio
  48. 6.8.5 Novartis Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Biologic Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson Biologic Drugs Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Biologic Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Biologic Drugs Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Biologic Drugs Sales by Country
  2. 7.1.1 North America Biologic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Biologic Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Biologic Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Biologic Drugs Market Size by Country
  6. 7.2.1 North America Biologic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Biologic Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Biologic Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Biologic Drugs Sales by Country
  2. 8.1.1 Europe Biologic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Biologic Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Biologic Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Biologic Drugs Market Size by Country
  6. 8.2.1 Europe Biologic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Biologic Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Biologic Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Biologic Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Biologic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Biologic Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Biologic Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Biologic Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Biologic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Biologic Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Biologic Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Biologic Drugs Sales by Country
  2. 10.1.1 South America Biologic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Biologic Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Biologic Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Biologic Drugs Market Size by Country
  6. 10.2.1 South America Biologic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Biologic Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Biologic Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Biologic Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Biologic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Biologic Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Biologic Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Biologic Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Biologic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Biologic Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Biologic Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Biologic Drugs Value Chain Analysis
  2. 12.1.1 Biologic Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Biologic Drugs Production Mode & Process
  7. 12.2 Biologic Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Biologic Drugs Distributors
  10. 12.2.3 Biologic Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst